HIP12 Activators comprise a set of chemical entities that indirectly elevate the functional performance of HIP12 by acting on various signaling mechanisms. Forskolin, through the elevation of cAMP levels, indirectly enhances HIP12 activity by activating PKA, which may phosphorylate substrates that augment HIP12's role in signaling cascades. Phorbol 12-myristate 13-acetate (PMA), as a PKC activator, can phosphorylate proteins within the same pathways as HIP12, potentially increasing its activity in processes such as vesicular trafficking. Ionomycin, by increasing intracellular calcium levels, can lead to the activation of calcium-dependent kinases that may modify HIP12's phosphorylation state, thus enhancing its function. Epigallocatechin Gallate (EGCG) inhibits protein kinases that could be involved in the negative regulation of HIP12, leading to an enhancement of its activity in endocytic pathways.
Furthermore, the inhibition of PI3K by LY294002 might lead to the enhancement of HIP12 activity by altering downstream effects on membrane trafficking and signal transduction, pathways where HIP12 is implicated. Sphingosine-1-phosphate, through its receptor-mediated signaling, could activate G-protein coupled cascades that potentially include the activation of HIP12 in vesicle formation. FTY720, a modulator of the same receptors, might similarly influence HIP12's role in cytoskeletal organization. Okadaic Acid and Calyculin A, by inhibiting protein phosphatases, could result in increased phosphorylation that may indirectly enhance HIP12's activity. Dibutyryl-cAMP and 8-Bromo-cAMP, as cAMP analogs, activate PKA and could enhance HIP12's activity through similar pathways. Thapsigargin, by disrupting calcium homeostasis, may also potentiate HIP12's function by activating calcium-dependent signaling pathways, highlighting a comprehensive network of indirect activators that collectively enhance HIP12's cellular function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which in turn activates PKA. PKA phosphorylation can enhance the activity of HIP12 by promoting its interaction with other proteins in signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which can phosphorylate HIP12 or related proteins, thereby enhancing HIP12's functional role in vesicular trafficking and membrane dynamics. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, activating calcium-dependent kinases and phosphatases that can modulate HIP12 activity by influencing its phosphorylation state. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits several protein kinases, potentially reducing inhibitory phosphorylation of HIP12, thus indirectly enhancing its activity in cellular processes such as endocytosis. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can modulate downstream signaling pathways to indirectly enhance HIP12 activity by altering membrane trafficking and signal transduction pathways that HIP12 is involved in. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
This lipid signaling molecule can bind to its receptors and activate G-protein coupled signaling cascades, which may include HIP12 activation as part of its role in endocytic vesicle formation and trafficking. | ||||||
FTY720 | 162359-56-0 | sc-202161 sc-202161A sc-202161B | 1 mg 5 mg 25 mg | $33.00 $77.00 $120.00 | 14 | |
FTY720 is a sphingosine-1-phosphate receptor modulator, which can enhance HIP12 activity through similar pathways as sphingosine-1-phosphate, potentially influencing HIP12's role in cytoskeletal rearrangement. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 and 2A, leading to increased phosphorylation levels within the cell, which could enhance the phosphorylation and thus the activity of HIP12 in certain signaling pathways. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A, like okadaic acid, inhibits protein phosphatases, which could result in the enhanced activity of HIP12 through increased phosphorylation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that activates PKA, thereby potentially enhancing HIP12 activity in pathways modulated by PKA, including those that govern vesicle trafficking and fusion. | ||||||